Amneal Pharmaceuticals (AMRX)
Developer and manufacturer of generics, injectables, biosimilars, and branded neurology medicines.
$18.97
vs last close−0.53 (−2.72%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 51.40% | 164.15M shares | |
|---|---|---|---|
| 313 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 76.10% | 243.03M shares | |
| 19 holders · as of Sep 21, 2026 | |||
| Adds to | 127.50% | ||
319.35M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 127.50%; nothing is left for Other.
13F, as of Jun 30, 2026
313 holders · 164.15M shares · 49 new positions · 185 increased · 87 reduced · 55 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 26.56M | 8.32% | +2.04M | Aug 7, 2026 |
| TPG GP A, LLC | 12.33M | 3.86% | 0 | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 12.14M | 3.80% | +812.8K | Aug 13, 2026 |
| Rubric Capital Management LP | 10.17M | 3.18% | −868.9K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 7.71M | 2.41% | +125.1K | Aug 13, 2026 |
| State Street Corp | 7.36M | 2.30% | +562.3K | Aug 7, 2026 |
| Dimensional Fund Advisors LP | 5.79M | 1.81% | +103.7K | Aug 11, 2026 |
| Geode Capital Management, LLC | 5.14M | 1.61% | +593.4K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Tushar Patel | 17.60% | 61.34M | 13D | Aug 12, 2026 |
| Patel Tushar Bhikhubhai | 15.70% | 48.58M | 13D | Mar 17, 2025 |
| Chintu Patel | 9.40% | 32.58M | 13D | Aug 12, 2026 |
| Chirag Patel | 8.40% | 29.10M | 13D | Aug 12, 2026 |
| Patel Chintu | 8.20% | 25.91M | 13D | Oct 7, 2025 |
| BlackRock, Inc. | 7.60% | 24.12M | 13G | Apr 27, 2026 |
| Patel Chirag K. | 7.10% | 22.18M | 13D | Aug 8, 2025 |
| Akram Mahesh | 6.56% | 20.56M | 13G | May 14, 2025 |
| Patel Dipan | 5.40% | 16.90M | 13D | Mar 26, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 13, 2026 | John Kielydirector | Sale | 50,000 | $17.64 | 210,252 |
| Aug 12, 2026 | Jason B. Dalyofficer: EVP, Chief Legal Officer | Sale | 210,000 | $17.40 | 35,171 |
| Aug 11, 2026 | Jason B. Dalyofficer: EVP, Chief Legal Officer | Sale | 6,613 | $17.70 | 245,171 |
| Aug 12, 2026 | Nikita Shahofficer: Executive Vice President | Sale | 146,403 | $17.51 | 253,390 |
| May 11, 2026 | Deborah M. Autordirector | Sale | 34,819 | $12.94 | 93,660 |
| Nov 17, 2025 | Ted C. Narkdirector | Sale | 50,000 | $11.72 | 291,029 |
| Nov 12, 2025 | Nikita Shahofficer: Executive Vice President | Sale | 131,856 | $11.92 | 146,403 |
House and Senate disclosures
Not reported.